New prophylactic treatment

Colin Kerr

Published: Thursday, April 1, 2021

Santen has announced the launch of Ducressa, a fixed-dose combination (FDC) of levofloxacin/ dexamethasone eye drops solution that is indicated for the prevention and treatment of inflammation, and the prevention of infection associated with cataract surgery in adults. “With the launch of this new FDC, many ophthalmologists now have a new approach in their practice to prevent infection in their cataract surgery patient,” said Prof Marc Coassin, University of Rome, Italy. www.santen.eu

Latest Articles

ESCRS Research Projects Make a Difference

EPICAT study continues tradition of practice-changing clinical studies.

Tablao Debates: Cataract-Refractive Edition

Lively debate format pairs EDOF lenses with trifocals in a dance for first prize in surgery choice.

Phakic IOLs for Myopia and Presbyopia

Many options for patients under age 60.

Effect of COVID-19 and Vaccine on Retinal Disease

Registry-based studies indicate risk for retinal vascular occlusions have not increased.

Going Beyond Cataract Camps

ESCRS expanding treatment opportunities in underserved areas.

Bridging the Gap Between Local and Global

New training programmes seek to reach hard-to-reach areas to meet growing patient needs.

2024 Congress Draws Global Audience, Strengthens Ties

Refractive EDOF with the Benefits of Monofocal

PureSee IOL studies indicate high patient satisfaction.

Making the Right IOL Decisions

Use of presbyopia-correcting lenses in post-corneal refractive surgery patients requires attention to multiple considerations.

Training to Target Global Cataract Blindness

Non-profit organisations look to innovative, scalable virtual reality training systems.